Stay updated on Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:57:22.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    A new revision label v3.5.0 was added and the previous v3.4.3 revision label was removed.
    Difference
    0.1%
    Check dated 2026-03-18T17:50:31.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T15:43:07.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Added 'Gastric cancer' as a topic label and included a 'Genetic and Rare Diseases Information Center' resource in the Resources section. This supplements patient information without modifying trial details.
    Difference
    0.2%
    Check dated 2026-02-18T07:30:47.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The page now shows a new revision tag: Revision: v3.4.2. The older notice about lapse in government funding and operating status has been removed.
    Difference
    0.5%
    Check dated 2026-02-11T04:26:44.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The update consists of an administrative notice about government funding and a revision tag from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T05:15:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial page.